Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction

Journal of Pineal Research

Volumn 56, Issue 3, 2014, Pages 283-294

  Miller, Suzanne L ^a   Yawno, Tamara ^a   Alers, Nicole O ^a   Castillo Melendez, Margie ^a   Supramaniam, Veena G ^a   Vanzyl, Niel ^a   Sabaretnam, Tharani ^a   Loose, Jan M ^a   Drummond, Grant R ^a   Walker, David W ^a   Jenkin, Graham ^a   Wallace, Euan M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

antenatal; brain injury; clinical trial; fetal growth restriction; intrauterine growth restriction; melatonin; sheep

Indexed keywords

MELATONIN; ANTIOXIDANT; NEUROPROTECTIVE AGENT;

ABSENCE OF SIDE EFFECTS; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN INJURY; BRAIN MALFORMATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORPUS STRIATUM; EVENING DOSAGE; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LIPID PEROXIDATION; MORNING DOSAGE; MYELINATION; NERVE FIBER; NEUROPATHY; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL; SHEEP; STANDING; SUCKLING ANIMAL; THALAMUS; WHITE MATTER; ANIMAL; BRAIN; CLINICAL TRIAL; DRUG EFFECTS; FETAL GROWTH RETARDATION; PATHOLOGY; PILOT STUDY; PREGNANCY;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BRAIN; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MELATONIN; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PILOT PROJECTS; PREGNANCY; SHEEP;

EID: 84896140675     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12121     Document Type: Article

References (54)

1. Gagnon R,. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003; 110: S99-S107.
2. van Wassenaer A,. Neurodevelopmental consequences of being born SGA. Pediatr Endocrinol Rev 2005; 2: 372-377.
3. Tolsa CB, Zimine S, Warfield SK, et al. Early alteration of structural and functional brain development in premature infants born with intrauterine growth restriction. Pediatr Res 2004; 56: 132-138.
4. Ramenghi LA, Martinelli A, de Carli A, et al. Cerebral maturation in IUGR and appropriate for gestational age preterm babies. Reprod Sci 2011; 18: 469-475.
5. Samuelsen GB, Pakkenberg B, Bogdanovic N, et al. Severe cell reduction in the future brain cortex in human growth-restricted fetuses and infants. Am J Obstet Gynecol 2007; 197: 56. e1-7
6. Eikenes L, Martinussen MP, Lund LK, et al. Being born small for gestational age reduces white matter integrity in adulthood: a prospective cohort study. Pediatr Res 2012; 72: 649-654.
7. Miller SL, Wallace EM, Walker DW,. Antioxidant therapies: a potential role in perinatal medicine. Neuroendocrinology 2012; 96: 13-23.
8. Gveric-Ahmetasevic S, Sunjic SB, Skala H, et al. Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers. Free Radic Res 2009; 43: 376-384.
9. Miller SL, Chai M, Loose J, et al. The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology 2007; 148: 1288-1295.
10. Myatt L,. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2011; 31 (Suppl): S66-S69.
11. Kilic U, Yilmaz B, Ugur M, et al. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012; 52: 228-235.
12. Reiter RJ,. The melatonin rhythm: both a clock and a calendar. Experientia 1993; 49: 654-664.
13. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
14. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
15. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites. AFMK and AMK. J Pineal Res 2013; 54: 245-257.
16. Welin AK, Svedin P, Lapatto R, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007; 61: 153-158.
17. Miller SL, Yan EB, Castillo-Melendez M, et al. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci 2005; 27: 200-210.
18. Golombek DA, Pevet P, Cardinali DP,. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev 1996; 20: 403-412.
19. Castillo-Melendez M, Baburamani AA, Cabalag C, et al. Experimental modelling of the consequences of brief late gestation asphyxia on newborn lamb behaviour and brain structure. PLoS ONE 2013; 8: e77377.
20. Mallard EC, Rees S, Stringer M, et al. Effects of chronic placental insufficiency on brain development in fetal sheep. Pediatr Res 1998; 43: 262-270.
21. Duncan JR, Cock ML, Suzuki K, et al. Chronic endotoxin exposure causes brain injury in the ovine fetus in the absence of hypoxemia. J Soc Gynecol Investig 2006; 13: 87-96.
22. Dean JM, George S, Naylor AS, et al. Partial neuroprotection with low-dose infusion of the alpha2-adrenergic receptor agonist clonidine after severe hypoxia in preterm fetal sheep. Neuropharmacology 2008; 55: 166-174.
23. Rangan GK, Tesch GH,. Quantification of renal pathology by image analysis. Nephrology (Carlton) 2007; 12: 553-558.
24. Alers NO, Jenkin G, Miller SL, et al. Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction-a phase I pilot clinical trial: study protocol. BMJ Open 2013; 3: e004141.
25. Callaway JK, Beart PM, Jarrott B,. A reliable procedure for comparison of antioxidants in rat brain homogenates. J Pharmacol Toxicol Methods 1998; 39: 155-162.
26. Supramaniam VG, Jenkin G, Loose J, et al. Chronic fetal hypoxia increases activin A concentrations in the late-pregnant sheep. BJOG 2006; 113: 102-109.
27. Back SA,. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 2006; 12: 129-140.
28. Baumann N, Pham-Dinh D,. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001; 81: 871-927.
29. Back SA, Riddle A, Hohimer AR,. Role of instrumented fetal sheep preparations in defining the pathogenesis of human periventricular white-matter injury. J Child Neurol 2006; 21: 582-589.
30. Bell JE, Becher JC, Wyatt B, et al. Brain damage and axonal injury in a Scottish cohort of neonatal deaths. Brain 2005; 128: 1070-1081.
31. Olivier P, Fontaine RH, Loron G, et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS ONE 2009; 4: e7128.
32. Yawno T, Castillo-Melendez M, Jenkin G, et al. Mechanisms of melatonin induced protection in the brain of late gestation fetal sheep in response to hypoxia. Dev Neurosci 2012; 34: 543-551.
33. Soothill PW, Nicolaides KH, Campbell S,. Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res Ed) 1987; 294: 1051-1053.
34. Wu YW, Croen LA, Shah SJ, et al. Cerebral palsy in a term population: risk factors and neuroimaging findings. Pediatrics 2006; 118: 690-697.
35. Korzeniewski SJ, Birbeck G, Delano MC, et al. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 2008; 23: 216-227.
36. Eixarch E, Batalle D, Illa M, et al. Neonatal neurobehavior and diffusion MRI changes in brain reorganization due to intrauterine growth restriction in a rabbit model. PLoS ONE 2012; 7: e31497.
37. Padilla N, Falcon C, Sanz-Cortes M, et al. Differential effects of intrauterine growth restriction on brain structure and development in preterm infants: a magnetic resonance imaging study. Brain Res 2011; 1382: 98-108.
38. Riddle A, Dean J, Buser JR, et al. Histopathological correlates of magnetic resonance imaging-defined chronic perinatal white matter injury. Ann Neurol 2011; 70: 493-507.
39. Esterbauer H, Schaur RJ, Zollner H,. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
40. Jahnke G, Marr M, Myers C, et al. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999; 50: 271-279.
41. Montine TJ, Amarnath V, Martin ME, et al. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 1996; 148: 89-93.
42. McCracken E, Valeriani V, Simpson C, et al. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab 2000; 20: 1529-1536.
43. Neely MD, Sidell KR, Graham DG, et al. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem 1999; 72: 2323-2333.
44. Sherriff FE, Bridges LR, Gentleman SM, et al. Markers of axonal injury in post mortem human brain. Acta Neuropathol 1994; 88: 433-439.
45. Riddle A, Luo NL, Manese M, et al. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J Neurosci 2006; 26: 3045-3055.
46. Tolcos M, Bateman E, O'dowd R, et al. Intrauterine growth restriction affects the maturation of myelin. Exp Neurol 2011; 232: 53-65.
47. Billiards SS, Haynes RL, Folkerth RD, et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008; 18: 153-163.
48. Gunn AJ, Bennet L,. Fetal hypoxia insults and patterns of brain injury: insights from animal models. Clin Perinatol 2009; 36: 579-593.
49. Mallard EC, Williams CE, Johnston BM, et al. Increased vulnerability to neuronal damage after umbilical cord occlusion in fetal sheep with advancing gestation. Am J Obstet Gynecol 1994; 170: 206-214.
50. Geva R, Eshel R, Leitner Y, et al. Memory functions of children born with asymmetric intrauterine growth restriction. Brain Res 2006; 1117: 186-194.
51. Medana IM, Esiri MM,. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 2003; 126: 515-530.
52. Perlson E, Maday S, Fu MM, et al. Retrograde axonal transport: pathways to cell death? Trends Neurosci 2010; 33: 335-344.
53. Yan T, Feng Y, Zhai Q,. Axon degeneration: mechanisms and implications of a distinct program from cell death. Neurochem Int 2010; 56: 529-534.
54. Back SA, Riddle A, Dean J, et al. The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant. Neurotherapeutics 2012; 9: 359-370.